TRIALECO
Discuss a pilot

Controlled study communication

Comms

Prepares approved-message workflows, clarification, reminders and escalation with a visible project status for each contact.

Module purpose

Support consistent communication without turning an automated channel into a source of medical advice.

Status

Public clinical and operational validation results and medical-device registration details have not been published. This module must not be treated as an approved medical device. Human approval remains mandatory for clinical, ethical and regulatory decisions.

Public clinical and operational validation results and medical-device registration details have not been published. This module must not be treated as an approved medical device. Human approval remains mandatory for clinical, ethical and regulatory decisions.

Inputs

  • Permitted communication scenario
  • Approved templates and languages
  • Event and urgency
  • Channel preferences and consent

How it works

  1. Selects an approved template
  2. Uses only allowed data
  3. Holds critical messages for review
  4. Records delivery, response, retry and escalation

Outputs

  • Draft or approved non-clinical message
  • Delivery and response status
  • Structured event
  • Project communication log

Human checkpoints

  • Consent and channel validation
  • Critical-message review
  • Clinical assessment of safety signals

Automation boundaries

  • Does not advise on treatment
  • Does not diagnose from a symptom
  • Does not conceal automated assistance

Module video

Comms: controlled communication

The film explains the module with a synthetic example. It is not evidence of clinical effectiveness, validation, compliance or regulatory approval.

1 min 44 secPublished
Open the full video series →